Clinical Trials at Mercy Clinic-Rolla-Cancer and Hematology
As of September 2026, 33 paid clinical trials are recruiting at Mercy Clinic-Rolla-Cancer and Hematology, located at Mercy Clinic Cancer and Hematology - Rolla Suite 310, 1605 Martin Springs Dr suite 310, Rolla, MO 65401, phone (573) 458-6379 in Rolla, Missouri. Active studies at this site cover conditions such as Malignant Solid Neoplasm, Chronic Lymphocytic Leukemia and Hematopoietic and Lymphatic System Neoplasm. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
33 clinical trials at Mercy Clinic-Rolla-Cancer and Hematology
·Clear filters·Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Family Communications After Genetic Testing
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Common conditions studied in Rolla
- Malignant Solid Neoplasm (5 active studies)
- Chronic Lymphocytic Leukemia (2 active studies)
- Hematopoietic and Lymphatic System Neoplasm (2 active studies)
- Hematopoietic and Lymphoid Cell Neoplasm (2 active studies)
- Plasma Cell Myeloma (2 active studies)
- Prostate Adenocarcinoma (2 active studies)
Leading research sponsors in Rolla
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- ECOG-ACRIN Cancer Research Group
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Rolla?
There are approximately 37 recruiting clinical trials in Rolla, Missouri listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Rolla pay participants?
Most recruiting trials in Rolla compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Rolla?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Rolla?
The most common conditions under active study in Rolla include Malignant Solid Neoplasm (5), Chronic Lymphocytic Leukemia (2), Hematopoietic and Lymphatic System Neoplasm (2), Hematopoietic and Lymphoid Cell Neoplasm (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Rolla?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Rolla on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Rolla?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Rolla?
Recruiting research sites in Rolla include Mercy Clinic-Rolla-Cancer and Hematology, Phelps Health Delbert Day Cancer Institute, Delbert Day Cancer Institute at PCRMC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Rolla right now?
The largest active categories in Rolla are Cancer & tumors (28), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Mercy Clinic-Rolla-Cancer and Hematology?
Mercy Clinic-Rolla-Cancer and Hematology is located at Mercy Clinic Cancer and Hematology - Rolla Suite 310, 1605 Martin Springs Dr suite 310, Rolla, MO 65401. Use the Google Maps link in the intro above to get directions.
How do I contact Mercy Clinic-Rolla-Cancer and Hematology?
You can reach Mercy Clinic-Rolla-Cancer and Hematology by phone at (573) 458-6379. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.